This is not the most recent version of the article. View current version (17 DEC 2013)

Intervention Protocol

Agomelatine versus other antidepressive agents for major depression

  1. Giuseppe Guaiana1,*,
  2. Sumeet Gupta2,
  3. Debbie Chiodo3,
  4. Simon JC Davies4

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 10 NOV 2010

DOI: 10.1002/14651858.CD008851


How to Cite

Guaiana G, Gupta S, Chiodo D, Davies SJC. Agomelatine versus other antidepressive agents for major depression (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 11. Art. No.: CD008851. DOI: 10.1002/14651858.CD008851.

Author Information

  1. 1

    University of Western Ontario, Department of Psychiatry, St Thomas, Ontario, Canada

  2. 2

    Tees, Esk & Wear Valleys NHS Foundation Trust, General Adult Psychiatry, Darlington, Durham, UK

  3. 3

    King's University College at the University of Western Ontario, Department of Psychology, London, Ontario, Canada

  4. 4

    University of Bristol, School of Social and Community Medicine, Bristol, UK

*Giuseppe Guaiana, Department of Psychiatry, University of Western Ontario, Regional Mental Health Care-Saint Thomas, 467 Sunset Drive, St Thomas, Ontario, N6P 3V9, Canada. Giuseppe.Guaiana@sjhc.london.on.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 10 NOV 2010

SEARCH

This is not the most recent version of the article. View current version (17 DEC 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

(1)  To determine the efficacy of agomelatine in alleviating acute symptoms of depressive illness in comparison to other antidepressants.

(2)  To review the acceptability of agomelatine in comparison with other antidepressant drugs.

(3)  To investigate the adverse effects of agomelatine, including general prevalence of side effects.